Swiss pharma giant Roche is investing $280 million to build a new biopharma manufacturing facility in Shanghai, as it doubles ...

UK-based pharma major AstraZeneca (LSE: AZN) has started construction on a new manufacturing site for small molecule drugs in ...

The global cholesterol API market is witnessing robust growth, driven by the expanding application of cholesterol-based raw materials across pharmaceuticals, biotechnology, cosmetics, and advanced ...

The biotech giant's new facility is part of a larger U.S. investment strategy, though it may roll back its buildout if the ...

An award-winning biomedical researcher, entrepreneur and consultant, Gloria Izu, is set to create opportunities for researchers, entrepreneurs, and young professionals in the fields of biotech, ...

Commerce officials approved an incentives package worth up to $13.1 million for the company, which plans to build a $700 million plant in the Wake County town. It's the latest drugmaker to target the ...

U.S.-based Waters Corp , which makes medical equipment used in clinical testing, has seen a spurt in demand from drugmakers ...

Controlling the entire cell therapy production process—from material receipt to product release—is “essential,” according to AstraZeneca, which says its new $300 million manufacturing facility will be ...

Genentech, considered one of the biotech industry’s founding companies, plans to build a $700 million, 700,000-square-foot manufacturing facility in Holly Springs. The company expects to employ 420 ...

The committee awarded a grant to Genentech, a Roche subsidiary, to open a 420-worker, drug-manufacturing plant in the ...

Scientists want to study the way your body’s gut microbes react and interact with psychedelic substances like magic mushrooms ...

Story April 14 - Third Harmonic Bio: The California biotech has abandoned plans to take its chronic spontaneous urticaria drug into phase ... Cherokee manufacturing plant in Riverside ...